Literature DB >> 35228694

PERK is a critical metabolic hub for immunosuppressive function in macrophages.

Lydia N Raines1, Haoxin Zhao1, Yuzhu Wang1,2, Heng-Yi Chen3, Hector Gallart-Ayala4, Pei-Chun Hsueh5,6, Wei Cao1, Yeojung Koh1, Ana Alamonte-Loya3, Pu-Ste Liu7, Julijana Ivanisevic4, Chan-Wang Jerry Lio3, Ping-Chih Ho5,6, Stanley Ching-Cheng Huang8,9.   

Abstract

Chronic inflammation triggers compensatory immunosuppression to stop inflammation and minimize tissue damage. Studies have demonstrated that endoplasmic reticulum (ER) stress augments the suppressive phenotypes of immune cells; however, the molecular mechanisms underpinning this process and how it links to the metabolic reprogramming of immunosuppressive macrophages remain elusive. In the present study, we report that the helper T cell 2 cytokine interleukin-4 and the tumor microenvironment increase the activity of a protein kinase RNA-like ER kinase (PERK)-signaling cascade in macrophages and promote immunosuppressive M2 activation and proliferation. Loss of PERK signaling impeded mitochondrial respiration and lipid oxidation critical for M2 macrophages. PERK activation mediated the upregulation of phosphoserine aminotransferase 1 (PSAT1) and serine biosynthesis via the downstream transcription factor ATF-4. Increased serine biosynthesis resulted in enhanced mitochondrial function and α-ketoglutarate production required for JMJD3-dependent epigenetic modification. Inhibition of PERK suppressed macrophage immunosuppressive activity and could enhance the efficacy of immune checkpoint programmed cell death protein 1 inhibition in melanoma. Our findings delineate a previously undescribed connection between PERK signaling and PSAT1-mediated serine metabolism critical for promoting immunosuppressive function in M2 macrophages.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35228694      PMCID: PMC9112288          DOI: 10.1038/s41590-022-01145-x

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   31.250


  61 in total

Review 1.  Endoplasmic reticulum stress in immunity.

Authors:  Sarah E Bettigole; Laurie H Glimcher
Journal:  Annu Rev Immunol       Date:  2014-12-10       Impact factor: 28.527

Review 2.  Macrophage Polarization.

Authors:  Peter J Murray
Journal:  Annu Rev Physiol       Date:  2016-10-21       Impact factor: 19.318

Review 3.  Metabolic Instruction of Immunity.

Authors:  Michael D Buck; Ryan T Sowell; Susan M Kaech; Erika L Pearce
Journal:  Cell       Date:  2017-05-04       Impact factor: 41.582

4.  Endoplasmic Reticulum Stress Responses in Intratumoral Immune Cells: Implications for Cancer Immunotherapy.

Authors:  Minkyung Song; Juan R Cubillos-Ruiz
Journal:  Trends Immunol       Date:  2019-01-03       Impact factor: 16.687

Review 5.  Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.

Authors:  Xiaoyun Li; Mathias Wenes; Pedro Romero; Stanley Ching-Cheng Huang; Sarah-Maria Fendt; Ping-Chih Ho
Journal:  Nat Rev Clin Oncol       Date:  2019-07       Impact factor: 66.675

Review 6.  Macrophage biology in development, homeostasis and disease.

Authors:  Thomas A Wynn; Ajay Chawla; Jeffrey W Pollard
Journal:  Nature       Date:  2013-04-25       Impact factor: 49.962

Review 7.  Macrophages, immunity, and metabolic disease.

Authors:  Joanne C McNelis; Jerrold M Olefsky
Journal:  Immunity       Date:  2014-07-17       Impact factor: 31.745

Review 8.  Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes.

Authors:  Jean-Pierre Etchegaray; Raul Mostoslavsky
Journal:  Mol Cell       Date:  2016-06-02       Impact factor: 17.970

Review 9.  Circles of Life: linking metabolic and epigenetic cycles to immunity.

Authors:  Chan-Wang Jerry Lio; Stanley Ching-Cheng Huang
Journal:  Immunology       Date:  2020-06-03       Impact factor: 7.397

Review 10.  The unfolded protein response in immunity and inflammation.

Authors:  Joep Grootjans; Arthur Kaser; Randal J Kaufman; Richard S Blumberg
Journal:  Nat Rev Immunol       Date:  2016-06-27       Impact factor: 53.106

View more
  9 in total

Review 1.  Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies.

Authors:  Jabar A Faraj; Ali Jihad Hemid Al-Athari; Sharaf El Din Mohie; Iman Kareem Kadhim; Noor Muhsen Jawad; Weaam J Abbas; Abduladheem Turki Jalil
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

Review 2.  Metabolic communication in the tumour-immune microenvironment.

Authors:  Kung-Chi Kao; Stefania Vilbois; Chin-Hsien Tsai; Ping-Chih Ho
Journal:  Nat Cell Biol       Date:  2022-10-13       Impact factor: 28.213

3.  Impact of Dexamethasone Preconditioning on Prevention of Development of Cognitive Impairment following Acute Inflammation.

Authors:  Wenjie Cheng; Yushan Song; Yanfang Liu; Xiaohua Sun; Wanlu Ren
Journal:  Contrast Media Mol Imaging       Date:  2022-06-14       Impact factor: 3.009

4.  PERK promotes immunosuppressive M2 macrophage phenotype by metabolic reprogramming and epigenetic modifications through the PERK-ATF4-PSAT1 axis.

Authors:  Uday P Pratap; Ratna K Vadlamudi
Journal:  Immunometabolism (Cobham)       Date:  2022-07-29

Review 5.  Breathe In, Breathe Out: Metabolic Regulation of Lung Macrophages in Host Defense Against Bacterial Infection.

Authors:  J Tucker Andrews; Daniel E Voth; Stanley Ching-Cheng Huang; Lu Huang
Journal:  Front Cell Infect Microbiol       Date:  2022-07-08       Impact factor: 6.073

Review 6.  Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment.

Authors:  Shilin Wang; Guohong Liu; Yirong Li; Yunbao Pan
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

7.  SHMT2 regulates serine metabolism to promote the progression and immunosuppression of papillary renal cell carcinoma.

Authors:  Weiyu Kong; Zhongyuan Wang; Nuoran Chen; Yiwen Mei; Yang Li; Yulin Yue
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

8.  An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy.

Authors:  Mingtao Feng; Huanhuan Cui; Wenjing Tu; Liangdong Li; Yang Gao; Lei Chen; Deheng Li; Xin Chen; Fengfeng Xu; Changshuai Zhou; Yiqun Cao
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

Review 9.  Metabolic guidance and stress in tumors modulate antigen-presenting cells.

Authors:  Jaeoh Park; Limei Wang; Ping-Chih Ho
Journal:  Oncogenesis       Date:  2022-10-16       Impact factor: 6.524

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.